How do CMS negotiated prices compare to value?

That is the question asked in a recent Health Affairs Forefront article by Peter Neumann, Josh Cohen, Sean Sullivan and Feng Xie. They compare the CMS negotiated prices for Initial Price Applicability Year (IPAY) 2027 against value-based prices (using QALYs) from the Tufts Cost-Effectiveness Analysis (CEA) Registry. The authors found that cost-effectiveness estimates varied among…

Read More

Let’s get moving on AI-discovered treatments

By STEVEN ZECOLA Recursion Pharmaceuticals announced results today for one its AI-discovered treatments. I was pleased to see the large, sustained reduction in polyps attributable to its treatment for Familial Adenomatous Polyposis.  Recursions’ oral medication will be viewed by the traditional scientific and regulatory community as “promising”. On the other hand, I was disappointed not…

Read More

How AI Is Reshaping Emergency Departments

We are building a more connected system that bridges acute and post-acute settings by uniting insights across the continuum. The insights empower clinicians with the information they need at the moment they need it, resulting in faster, safer, and more human-centered care. The post How AI Is Reshaping Emergency Departments appeared first on MedCity News.

Read More

Trump Administration Actions to Curb Data Collection Related to Sexual Orientation and Gender Identity (SOGI)

This brief describes Trump Administration efforts to scale back or modify data collection on sexual orientation and gender identity variables in federal surveys. It specifically focuses on changes in three national surveys that are representative of these efforts: the National Health Interview Survey (NHIS), the Medicare Current Beneficiary Survey (MCBS), and the National Crime Victimization…

Read More